Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.770M |
Day Range | - - - |
52 Wk Range | 25.920 - 35.950 |
Market Cap | $12.918B |
P/E Ratio | 11.111 |
Dividend Yield | 2.990% |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 2.89% |
Days to Cover | 6.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.
Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by B of A Securities on Friday, April 12, 2024. The analyst firm set a price target for 38.00 expecting RPRX to rise to within 12 months (a possible 31.40% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $28.9199 last updated April 25, 2024 at 6:30 PM EDT.
The next Royalty Pharma (RPRX) dividend date is projected to be Thursday, May 16, 2024.
Royalty Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.